Literature DB >> 16036051

A heart failure specialist's perspective on cardiac surgery for heart failure.

Carl V Leier1.   

Abstract

Aside from cardiac transplantation, ventricular assist devices, and the total artificial heart, cardiac surgery now also plays a major role in the overall management of the heart failure patient. For patients with heart failure, cardiac surgery has steadily moved from being a predominant rescue procedure (eg, aneursymectomy, rupture repair, transplantation) to surgical interventions that can prevent or delay the progression of cardiac dysfunction and failure; these operations now include coronary artery bypass surgery, ventricular restoration, and valvular repair/replacement. This article discusses the role and impact of these specific surgical interventions in the setting of ventricular dysfunction and heart failure.

Entities:  

Mesh:

Year:  2005        PMID: 16036051     DOI: 10.1007/s11897-005-0007-1

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  49 in total

Review 1.  Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention and medical therapy for multivessel disease with and without left ventricular dysfunction.

Authors:  Amitra E B Caines; Malek G Massad; Jacques Kpodonu; Abdallah G Rebeiz; Alexander Evans; Alexander S Geha
Journal:  Cardiology       Date:  2004       Impact factor: 1.869

Review 2.  Myocardial viability: methods of assessment and clinical relevance.

Authors:  A S Iskandrian; J Heo; H R Schelbert
Journal:  Am Heart J       Date:  1996-12       Impact factor: 4.749

3.  Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography.

Authors:  J L Monin; M Monchi; V Gest; A M Duval-Moulin; J L Dubois-Rande; P Gueret
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

4.  Valvular replacement for aortic stenosis on patients in NYHA class III and IV. Early and long term results.

Authors:  J F Obadia; A Eker; G Rescigno; C Flamens; J F Chassignolle
Journal:  J Cardiovasc Surg (Torino)       Date:  1995-06       Impact factor: 1.888

5.  Mitral valve surgery in patients with poor left ventricular function.

Authors:  M Rothenburger; A Rukosujew; D Hammel; A Dorenkamp; C Schmidt; C Schmid; T Wichter; H H Scheld
Journal:  Thorac Cardiovasc Surg       Date:  2002-12       Impact factor: 1.827

6.  Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory.

Authors:  Rick A Nishimura; J Aaron Grantham; Heidi M Connolly; Hartzell V Schaff; Stuart T Higano; David R Holmes
Journal:  Circulation       Date:  2002-08-13       Impact factor: 29.690

7.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients.

Authors:  W L Henry; R O Bonow; J S Borer; J H Ware; K M Kent; D R Redwood; C L McIntosh; A G Morrow; S E Epstein
Journal:  Circulation       Date:  1980-03       Impact factor: 29.690

9.  Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars.

Authors:  V Dor; M Sabatier; M Di Donato; F Montiglio; A Toso; M Maioli
Journal:  J Thorac Cardiovasc Surg       Date:  1998-07       Impact factor: 5.209

10.  Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration.

Authors:  L Menicanti; M Di Donato; A Frigiola; G Buckberg; C Santambrogio; M Ranucci; D Santo
Journal:  J Thorac Cardiovasc Surg       Date:  2002-06       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.